Navigation Links
LMS integrated obstetrics solution achieves general availability

MONTREAL, Sept. 24 /PRNewswire-FirstCall/ - LMS Medical Systems (AMEX:LMZ; TSX:LMZ), a healthcare technology company and developer of the CALM(R) clinical information system and risk management software for obstetrics, today announced that Horizon Perinatal Care(TM), the first obstetrics (OB)/perinatal information system designed to support continuity of care between the labor and delivery (L&D) department and other hospital departments and units, developed in conjunction with McKesson Provider Technologies, has become generally available in the marketplace.

Horizon Perinatal Care seamlessly integrates with McKesson's enterprise clinical systems to provide ready access to historical patient information and eliminate redundant charting in support of providing safer, more efficient care to baby and mother. The integrated solution combines fetal strip archival and surveillance capabilities with McKesson's Horizon Clinicals(R) suite of solutions that are used in obstetrical care such as enterprise clinical history and interventions, documentation and bar-code medication administration.

"This milestone is the result of a joint development effort on the part of many dedicated people at both companies," said Diane Cote, President and CEO of LMS. "Bringing the product to life with LMS obstetrical solutions will mean safer deliveries for expectant mothers while providing clinicians a simpler, much needed system within which to work."

About LMS: LMS is a leader in the application of advanced mathematical modeling and neural networks for medical use. The LMS CALM Suite provides physicians, nursing staff, risk managers and hospital administrators with OB clinical information systems and risk management tools designed to improve outcomes and patient care for mothers and their infants during childbirth.

Horizon Perinatal Care is a trademark of McKesson.

Except for historical information contained herein, the matters discussed in this news release are forward-looking statements. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed implied by the forward-looking statements including, but without limitation, economic conditions in general and in the healthcare market, the demand for and market for our products in domestic and international markets, our current dependence on the CALM product suite, the challenges associated with developing new products and obtaining regulatory approvals if necessary, research and development activities, the uncertainty of acceptance of our products by the medical community, the lengthy sales cycle for our products, third party reimbursement, competition in our markets, including the potential introduction of competitive products by others, our dependence on our distributors, physician training, enforceability and the costs of enforcement of our patents, potential infringements of our patents and the other factors set forth from time to time in the Company's filings with the United States Securities and Exchange Commission and with the Canadian Securities Commissions. The Company has no intention of or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Integrated Disease Surveillance Project Soon In The Country
2. Integrated Child Development Scheme
3. Mumbai to Have Integrated Trauma Care Facility
4. Latest IPCC Report Highlights Need for Integrated Climate/human Behavior Models
5. Integrated Trauma Care Facility in Mumbai
6. Negligence Cases in the Obstetrics Department Increases Fatality Rates
7. Malpractice Worry Discouraging Medical Students From Taking Up Obstetrics And Gynecology
8. Half a Million Dollars Offered for GPs With Expertise in Anesthetics and Obstetrics
9. TIZANIDINE - New solution to chronic headache
10. A Solution To Quit Smoking Without Gaining Weight
11. Radiation Therapy An Effective Solution For Recurrent Prostate Cancer
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the ... Table 1-1 ). More than 3.7 billion people under the age of 50 ... (HSV-1), according to WHO's first global estimates of HSV-1 infection . , "The data ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television ... an interesting show that delves into an array of issues that are presently affecting ... benefit from open dialogue, this show is changing the subjects consumers focus on, one ...
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... California (PRWEB) , ... November 27, 2015 , ... Avid ... Joplin Ann Arbor Michigan boxing style concert posters. This is one of Joplin's most ... the Canterbury House at the University of Michigan in Ann Arbor. The According to ...
(Date:11/26/2015)... ... 26, 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday ... the Black Friday and Cyber Monday massage chair sales to receive the ... and low to find the best massage chair deals, they can see all of ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... au traitement photodynamique au Bremachlorin contre le cancer ... approche consistant à combiner l,immunothérapie au traitement photodynamique ... --> Une nouvelle approche consistant ... contre le cancer avancé.    ...
(Date:11/27/2015)... 2015 --> ... online. The potential to save costs, improve treatment quality ... from fully exploited as yet. Here, particular emphasis is ... via mobile tablet or directly at the patients, bedside. ... ) -->      (Photo: ...
(Date:11/27/2015)... Ein neuer Kombinationsansatz vereint ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... Clinical Cancer Research vom 6. November ... vom 6. November 2015 berichtet. --> ...
Breaking Medicine Technology: